Evaluation oncotype DX® 21‐gene recurrence score and clinicopathological parameters: a single institutional experience
Sign Up to like & getrecommendations! Published in 2023 at "Histopathology"
DOI: 10.1111/his.14863
Abstract: Oncotype DX recurrence score (RS) is a clinically validated assay, which predicts the likelihood of disease recurrence in oestrogen receptor‐positive/HER2‐negative (ER+/HER2−) breast cancer (BC). In this study we aimed to compare the performance of Oncotype… read more here.
Keywords: clinicopathological parameters; oncotype gene; recurrence score; recurrence ... See more keywords